Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Akero Therapeutics (AKRO)

:AKRO

US Market

AKRO

Akero Therapeutics

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Akero Therapeutics (AKRO) Stock News & Sentiment

599 Followers

Akero Therapeutics’ Efruxifermin Study: A Potential Game-Changer for NASH/MASH Treatment

Company Announcements

Akero Therapeutics’ Efruxifermin Study: A Potential Game-Changer for NASH/MASH Treatment

25d ago

Akero Therapeutics Elects New Directors at Annual Meeting

Company Announcements

Akero Therapeutics Elects New Directors at Annual Meeting

2M ago

Buy Rating for Akero Therapeutics Driven by EFX’s Promising Position in MASH Treatment and Market Potential

Ratings

Buy Rating for Akero Therapeutics Driven by EFX’s Promising Position in MASH Treatment and Market Potential

2M ago

3 Best Stocks to Buy Now, 5/27/2025, According to Top Analysts

Market News

3 Best Stocks to Buy Now, 5/27/2025, According to Top Analysts

2M ago

Akero Therapeutics’ Promising Developments and Financial Strength Support Buy Rating with $73 Price Target

Ratings

Akero Therapeutics’ Promising Developments and Financial Strength Support Buy Rating with $73 Price Target

2M ago

Akero Therapeutics Advances in MASH Treatment Research

Company Announcements

Akero Therapeutics Advances in MASH Treatment Research

2M ago

Akero Therapeutics: Strong Financial Health and Promising Clinical Data Justify Buy Rating

Ratings

Akero Therapeutics: Strong Financial Health and Promising Clinical Data Justify Buy Rating

2M ago

More AKRO News >

AKRO News on the Web

2025-07-18

RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure

Zacks

Neutral

2025-07-18

FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

Zacks

Neutral

2025-07-17

AstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage Studies

Zacks

Neutral

2025-07-17

Mirum Gains 35% in 3 Months: How Should You Play the Stock?

Zacks

Neutral

2025-07-16

Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag

Zacks

Neutral

2025-07-15

Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer

Zacks

Neutral

2025-06-13

Jefferies sees Akero, Scholar Rock as 'promising' takeover targets

The Fly

Neutral

2025-05-29

Why Akero Therapeutics, Inc.’s (AKRO) Stock Is Up 5.31%

AAII

Neutral

News Score - Last 7 Days

Neutral

AKRO

Sector Average

Media Buzz

This Week6 articles

Weekly Average1.5 articles

News Sentiment

This Week59%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AKRO’s Media Buzz Sentiment?

6 articles about AKRO were published this week. In an average week, 1.5 articles are published.

What is AKRO’s weekly average amount of articles?

In an average week, 1.5 articles about AKRO are published.

What is AKRO’s News Sentiment?

59% of articles about AKRO were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

NEVIPascal Biosciences Inc

HRMYHarmony Biosciences Holdings

JNJJohnson & Johnson

ABTAbbott Laboratories

SRPTSarepta Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing